Transplant Diagnostics Market

The report "Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product(Instrument, Reagent, Software), Application(HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User, & Region - Global Forecasts to 2028", is projected to reach USD 6.8 billion by 2028 from USD 4.4 billion in 2022, at a CAGR of 7.4% during the forecast period. Organ transplants have gradually improved over the past 20 years and typically produce excellent results in children and young adults. However, the proportion of elderly transplant patients with comorbidities is increasing, posing a greater challenge. When compared to dialysis, renal transplants increase patient survival, and patients with liver, heart, or lung diseases that are incurable must receive life-saving transplants. The activity of solid organ transplant programmes has been steadily increasing, but it still falls short of global needs and varies greatly between nations. Transplanting solid organs is crucial for advanced and established medical systems.

Browse 168 market data Tables and 44 Figures spread through 260 Pages and in-depth TOC on "Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product(Instrument, Reagent, Software), Application(HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User, & Region - Global Forecasts to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/global-transplant-diagnostics-market-2531061.html

Molecular assay technologies segment to register a significant growth rate over the forecast period of 2022-2028

Based on Technology, molecular assay technologies are segmented to witness the highest growth during the forecast period. Molecular assay technologies are segmented into PCR-Based molecular assays and sequencing-based molecular assays. PCR-based molecular assays are further segmented into Real-time PCR, Sequence-specific primer, Sequence-specific Oligonucleotide and other PCR-based molecular assays.

Sequence-specific Oligonucleotide is growing at the highest CAGR of 9.5%.

The Reagents & Consumables holds the largest share in the Product and Service segment of the Transplant diagnostic market.

The reagents and consumables is projected to reach USD 5,131.0 million from USD USD 3,265.2 million in 2022 with the CAGR of 7.8%.

Based on End users, the transplant diagnostic market is segmented into Hospitals and Diagnostic centers, Research & Academic Institutes and Independent reference laboratories. The Independent reference laboratories segment accounted for the largest share of the transplant diagnostic market. The growing number of organ transplant procedures and growing number of diagnostic labs across emerging countries are helping the independent diagnostic centers to hold the largest share.

North America  to register major growth in the market during the forecast period

North America transplant diagnostic market is anticipated to register the highest growth over the forecast period of 2022 to 2028. North America accounted for the largest share of 45.5% of the transplant diagnostic market in 2022. This market is projected to reach USD 3.1 billion by 2028 from USD 2.0 billion in 2022, at a CAGR of 7.6% during the forecast period. North America holds 45.5% share of the total antimicrobial susceptibility testing market. The large share of North America can be attributed due to the growth in the geriatric population and the increase in infectious diseases., Asia-Pacific is expected to experience significant development.

As of 2022, prominent players are Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.F-Hoffman-LA-Roche, and Thermo fisher Scientific.

Don’t miss out on business opportunities in Transplant Diagnostics Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]